Therapeutic Innovation : Discovery Across Boundaries
U1177 (formerly U761), directed by Pr. Benoit Deprez, is dedicated to drug design, discovery and selection.
The Lab's mission is to design and study compounds that modulates selected molecular targets in a desired way to treat infectious and metabolic diseases.
We are open to any type of collaboration with biologists or chemist from academia and industry where medicinal chemistry, in vitro pharmacology and pharmacokinetics enable or accelerate the translation of new therapeutic concept into drug discovery.
Our researchers are committed to the highest standards of scientific quality and integrity in everything they do. We use up-to date electronic lab books to sustainably capitalize knowledge and facilitate collaborations between multiple research sites.
Most of our researchers are also faculty members who teach in PharmD and MSc courses in pharmacy, drug discovery, medicinal chemistry, organic chemistry, and R&D strategies.
Chapuis, J., et al Alzheimer’s genetic risk factor FERMT2. Acta Neuropath.,2016. doi:1-12.10.1007/s00401-016-1652-z
Bauters, D., et al. ADAMTS5 & adipogenesis Thromb Haemost,2016, 116(4). doi:10.1160/th16-01-0015
Prevet, H., et al. Microwave-assisted synthesis of fragments . Tetrahedron Letters,2016,57(26):2888-2894. doi:10.1016/j.tetlet.2016.05.065
Letronne, F., et al ADAM30 in Alzheimer's Disease. EBioMedicine,2016: in press. doi:10.1016/j.ebiom.2016.06.002 OPEN ACCESS
Probst, N. P., et al. Palladium-free Sonogashira-type cross-coupling reaction. Tet. Lett.,2016, 57(10): 1066-1070. doi:10.1016/j.tetlet.2016.01.070
Bosc, D., et al. KTGS in drug discovery and chemical biology. Fut. Med. Chem.2016: in press. doi:10.4155/fmc-2015-0007 OPEN ACCESS
Broeders, E. M., et al. Chenodeoxycholic Acid Increases BAT Activity. Cell Metabolism,2015, 22(3): 418-426.